Ingersoll Rand Inc. (IR) Stock Price & How to Invest

Ingersoll Rand is a global industrial-technology company built around mission-critical air, fluid, gas, and medical technologies. It operates through two segments: Industrial Technologies and Services, which sells air compressors, vacuum and blower systems, air treatment, power tools, and lifting equipment; and Precision and Science Technologies, which makes highly engineered pumps and fluid-management systems for medical, life-science, and specialty industrial uses. The company was formed in 2020 when Gardner Denver merged with the Industrial segment of the old Ingersoll-Rand, and it sells under brands such as Ingersoll Rand, Gardner Denver, Nash, and many acquired niche names. A large share of revenue comes from aftermarket parts, consumables, and service on a big installed base, which makes results steadier than a pure equipment maker. Ingersoll Rand is headquartered in Davidson, North Carolina.

The investment picture centers on IRX, the company's proprietary operating system for continuous improvement, pricing discipline, and integrating acquisitions. Management pairs organic growth with a steady stream of bolt-on deals in fragmented compression and flow-control niches, funding them with strong free cash flow. That combination has driven margin expansion and consistent cash generation: trailing revenue reached about $7.9 billion as of the June 2026 quarter, with an operating margin near 17% and free cash flow of about $1.1 billion. The market rewards it with a premium multiple relative to the average industrial (about 20 times forward earnings as of October 2026), though the stock was down about 1.5% year to date and about 22% below its 52-week high on October 16, 2026, even after second-quarter revenue of about $2.05 billion (up about 8.5%) and adjusted EPS of $0.86 topped the $0.83 estimate. The bet is that mission-critical products, high aftermarket content, and disciplined capital allocation keep compounding through cycles, while the risks are the cyclicality of industrial capital spending, the execution demands of frequent M&A, and a valuation that already prices in continued quality.

Ingersoll Rand's end markets are cyclical and tied to global industrial capital spending, manufacturing activity, and specific verticals like energy and semiconductors, so downturns can slow orders and short-cycle revenue. The serial-acquisition strategy carries integration, execution, and valuation risk, and heavy reliance on M&A means growth can disappoint if the deal pipeline slows or purchase multiples rise. GAAP earnings dipped in 2025 (net income about $581 million versus about $839 million in 2024), so trailing GAAP P/E is about 32 even though forward P/E is near 20. Foreign-exchange swings, tariffs, and supply-chain disruptions can pressure results given the global footprint. Competition across compression and flow control is intense, including from larger and lower-cost rivals. Some analysts trimmed targets in late September 2026 (Goldman Sachs to $87, Deutsche Bank to $85), and the stock still trades at a premium to the average industrial, so any slowdown in margin gains or capital deployment can weigh on the multiple.

13 analysts publish price targets on IR, averaging $94.71 against a $77.78 price as of October 2026, or +21.8%. The published targets run from $82.00 to $109.00, a narrow spread, and the ratings split 7 buy, 7 hold, 0 sell. Over the last six months there have been 2 raises and 5 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full IR forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Ingersoll Rand Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. IRX operating system and margins. IRX is Ingersoll Rand's proprietary system for continuous improvement, pricing, and operational execution. The most optimistic published target, $109.00, assumes this works close to its best case.

The case against. Ingersoll Rand's end markets are cyclical and tied to global industrial capital spending, manufacturing activity, and specific verticals like energy and semiconductors, so downturns can slow orders and short-cycle revenue. The most pessimistic target, $82.00, is roughly what IR is worth if this bites instead.

Read the full bull and bear case on IR, including what would have to change to break either one. Walnut is not an investment adviser.

No. Ingersoll Rand Inc. (IR) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Ingersoll Rand Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$7.9 billion
• Revenue growth (Q2 2026, yoy): ~8.5% (Q2 revenue ~$2.05 billion)
• Margins (TTM): Gross ~43%; operating ~17%; net ~12%
• Adjusted EPS (Q2 2026): $0.86 vs $0.83 estimate
• P/E: ~32x trailing GAAP; ~20x forward
• Free cash flow (TTM): ~$1.1 billion
• Market cap: ~$30 billion
• Dividend yield: ~0.1% ($0.08 a share annually)

At $78.60 on October 16, 2026, Ingersoll Rand traded near 20 times forward earnings and about 17 times EV/EBITDA, a premium to the average industrial that reflects its aftermarket mix and IRX execution but is lower than earlier in the year after the shares fell from a 52-week high near $101. Analysts expect adjusted EPS of about $3.55 for 2026 (inside the $3.45-3.57 range management set at the start of the year) and about $3.91 for 2027. Third-quarter results on October 29, 2026 carry consensus of about $0.90 a share on $2.05 billion of revenue.

Other names that sit close to IR: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get IR exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so IR sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where IR fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Ingersoll Rand (IR) is a high-quality flow-control and industrial-technology compounder whose IRX operating system, sticky aftermarket revenue, and steady bolt-on acquisitions give it durable margins and free cash flow (about $1.1 billion over the trailing year), while cyclical end markets, acquisition-integration risk, and a valuation of about 20 times forward earnings remain the key trade-offs. The shares have gone nowhere in 2026 despite revenue growth picking up to about 8.5% in the June quarter.

Whether IR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IR a buy or a sell?, and where the stock could go from here in the IR stock forecast.

For income investors, whether IR pays a dividend and how the payout looks is covered in does IR pay a dividend? And to weigh IR against a peer, read the full side-by-side comparisons: IR vs XYL and IR vs FLS.